OrsoBio Alternatives & Competitors
12 companies similar to OrsoBio — Advancing first-in-class therapies to restore energy homeostasis
Companies similar to OrsoBio
Inversago Pharma
Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrot...
Inventiva Pharma
A clinical-stage biopharmaceutical company focused on the development of oral small molecu...
AusperBio
Transforming Patient Lives For a Better Tomorrow
HighTide Therapeutics
East Meets West—The Quest for Cure
Rival Readout
Competing with OrsoBio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Sciwind Biosciences
Pioneering treatments to empower physicians in addressing metabolic disorders with advance...
Biocon
Transforming Healthcare. Transforming Lives.
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
BioAge Labs
We are harnessing the biology of human aging to develop novel targets and therapies for me...
Pathalys Pharma
Our mission is to improve the lives of patients through enhanced therapeutics to advance t...
Glyscend Therapeutics
Advancing a new class of oral gut-targeted polymeric drugs for the treatment of T2D and Ob...
Intellia Therapeutics, Inc.
Developing curative genome editing treatments
About OrsoBio
OrsoBio, founded in 2021, is a United States-based, clinical-stage biopharmaceutical company aiming to transform the treatment of severe metabolic disorders. Guided by its slogan, "Advancing first-in-class therapies to restore energy homeostasis", the company focuses on innovative treatments for conditions such as type...
Developing first-in-class therapies, Targeting energy metabolism pathways, Restoring energy homeostasis
Patients with severe metabolic disorders, Individuals with obesity and diabetes, Healthcare providers focused on metabolic health
First-in-class Therapies, Energy Homeostasis, Metabolic Disorders, Type 2 Diabetes, Severe Dyslipidemias, Lipodystrophies, Nonalcoholic Steatohepatitis, Clinical-stage Biopharmaceutical, Energy Metabolism Pathways, Therapeutics Development, Restoring Energy Balance, Underlying Cause Treatment, Severe Metabolic Conditions, Private Healthcare Innovation, Biopharmaceutical Research
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around OrsoBio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at OrsoBio on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.